Tokyo, Japan

Kunihiro Ninomiya, Deceased


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • late of Machida, JP (1996)
  • late of Tokyo, JP (1995 - 1999)

Company Filing History:


Years Active: 1995-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kunihiro Ninomiya: A Legacy of Innovation in Medicine

Introduction

Kunihiro Ninomiya was a notable inventor whose contributions to the field of medicine have left a lasting impact. Based in Tokyo, Japan, he was known for his innovative work in developing compounds that address significant health issues. His dedication to research and development has resulted in several patents that showcase his ingenuity.

Latest Patents

Ninomiya held a total of 3 patents during his career. Among his latest inventions is a novel 4-acylaminopyridine derivative, which is represented by a specific formula. This compound is particularly noteworthy for its potential use as a medicine to treat disturbances of memory, such as senile dementia and Alzheimer's disease. The 4-acylaminopyridine derivative works by directly activating malfunctioned cholinergic neurons, offering hope for those affected by these conditions.

Career Highlights

Throughout his career, Kunihiro Ninomiya worked with prominent companies, including Mitsubishi Chemical Corporation and Mitsubishi Kasei Corporation. His experience in these organizations allowed him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers included Mamoru Sugano and Akihiro Tobe. Their collective efforts in research and development have further advanced the field of medicinal chemistry.

Conclusion

Kunihiro Ninomiya's legacy as an inventor is marked by his innovative contributions to medicine. His work continues to inspire future generations of researchers and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…